September 25, 2018

Seattle Children’s cancer survivor becomes a caregiver

Four years ago, KING 5 shared Milton Wright's story after he had completed immunotherapy treatment at Seattle Children's. Milton was the second patient to beat leukemia with T-cell immunotherapy, and after nearly 12 years of battling cancer, it's easy to understand why he would shy away from the medical setting.
September 24, 2018

Trial to assess CAR T-cell therapy for relapsed, refractory solid tumors

STRIvE-01, a trial underway at Seattle Children's, will evaluate chimeric antigen receptor T-cell therapy for children and young adults with relapsed or refractory noncentral nervous system EGFR-expressing solid tumors.
September 16, 2018

‘As quick as you can get’: Toddler cancer free after 10 days of immunotherapy

Harper Beare, just shy of her second birthday, has spent nearly half her life in and out of hospitals after being diagnosed with leukemia. After four rounds of chemotherapy didn't put Harper into remission, her doctor recommended an immunotherapy trial at Seattle Children's.
September 12, 2018

Further development of CAR-T cell therapies in solid tumors will need industry, says GlobalData

Just as Seattle Children's Hospital has initiated a study of two CAR-T cell therapies in young people with relapsed or refractory non-central nervous system epidermal growth factor receptor (EGFR)-positive solid tumors, GlobalData states that if study data are positive, collaboration with industry will be required to support further clinical development and commercialization.